Press Releases Pangenomic Health Inc.

Equities

NARA

CA69842E3041

Delayed Canadian Securities Exchange Other stock markets 10:27:36 2024-04-30 am EDT			5-day change	1st Jan Change
0.08 ^CAD	0.00%		0.00%	-60.00%

Feb. 19	PanGenomic Health plans to withdraw shares from Aquis Stock Exchange	AN
Feb. 16	Pangenomic Health Inc. Announces Changes to Board of Directors	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PanGenomic Health Announces Application for a Management Cease Trade Order For Late Filing of Audited Annual Financial Statements	Apr. 12	AQ
PanGenomic Health Announces Completion of Consolidation	Mar. 21	AQ
CSE Bulletin: Consolidation - PanGenomic Health Inc. (NARA)	Mar. 19	NE
PanGenomic Health Announces Proposed Consolidation and Completion of Withdrawal from AQSE	Mar. 18	AQ
PanGenomic Health Announces Withdrawal from AQSE	Feb. 20	AQ
PanGenomic Health Announces Changes to Board of Directors	Feb. 16	AQ
PanGenomic Health Signs Letter of Intent with Crescita Capital for $5 Million Equity Drawdown Facility	Jan. 09	AQ
PanGenomic Health Subsidiary Introduces Point-of-Care Vitamin D Test for the Dental Implant Industry	Dec. 06	AQ
How Technology Can Be a Game Changer in Mental Health Treatment and AI Is Leading the Way	Nov. 22	NE
PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests	Nov. 17	AQ
PanGenomic Health Intends to Close Shares for Debt Settlement	Nov. 01	AQ
PanGenomic Health Announces Financial Results for Half Year Ended June 30, 2023	23-08-30	AQ
PanGenomic Health Retains Social Media and Data Intelligence Advisory Firm and Announces Shares for Debt Settlement	23-08-09	AQ
PanGenomic Health Announces Director Resignations	23-07-13	AQ
PanGenomic Health Subsidiary Launches Vitamin D Health Assessments and Announces Corporate Appointments	23-07-06	AQ
PanGenomic Health Provides Update for NARA Product and Conversational AI	23-06-06	AQ
PanGenomic Health Signs Non-Binding Letter of intent for an Exclusive Special Purpose Licence of the CyberPatient AI Medical Education Platform	23-05-30	AQ
PanGenomic Health Announces Financial Results for the 2022 Fiscal Year	23-05-02	AQ
PanGenomic Health Announces AGM Results	23-05-02	AQ
PanGenomic Health Subsidiary Signs Master Services Agreement with Psy Integrated and Announces Repricing of Outstanding Warrants	23-04-21	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Pangenomic Health Inc.

Equities

NARA

CA69842E3041

Press Releases

Filters